World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
125
Citations
74205
World Ranking
3038
National Ranking
1676

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

K. Kian Ang was affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research spanned the main field of Medicine, with specific contributions in Surgery, Rheumatology, and Epidemiology. The scientist's work covered multiple subfields, reflecting a diverse medical research portfolio.

The major topics addressed in their research included:

  • Osteoarthritis Treatment and Mechanisms
  • Surgical Sutures and Adhesives
  • Total Knee Arthroplasty Outcomes
  • Reconstructive Facial Surgery Techniques
  • Reconstructive Surgery and Microvascular Techniques
  • Nonmelanoma Skin Cancer Studies

K. Kian Ang contributed to the scientific literature with publications in venues such as Interdisciplinary Medicine and the British Journal of Surgery. Their recent papers include:

  • "Application of adhesives in the treatment of cartilage repair," 2024, published in Interdisciplinary Medicine
  • "507 Total Lower Lip Reconstruction: A Systematic Review and Treatment Algorithm," 2021, published in British Journal of Surgery

Throughout their career, K. Kian Ang collaborated with several co-authors, including Haoyang Feng, Pengfei Guan, Junji Li, Huan Meng, and Jian Yang. These collaborations contributed to multidisciplinary perspectives within their work.

The scientist was recognized as a Member of the Association of American Physicians. No specific year was noted for this award.

Best Publications

  • Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

    K Kian Ang;Jonathan Harris;Richard Wheeler;Randal Weber

  • Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

    James A. Bonner;Paul M. Harari;Jordi Giralt;Nozar Azarnia

  • Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

    James A Bonner;Paul M Harari;Jordi Giralt;Roger B Cohen

  • Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).

    Jacques Bernier;Jay S. Cooper;T. F. Pajak;M. Van Glabbeke

  • A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

    Karen K. Fu;Thomas F. Pajak;Andy Trotti;Christopher U. Jones

  • Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.

    K. Kian Ang;Brian A. Berkey;Xiaoyu Tu;Hua Zhong Zhang

  • Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

    Mitchell Machtay;Jennifer Moughan;Andrew Trotti;Adam S. Garden

  • An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

    Lauren Averett Byers;Lixia Diao;Jing Wang;Pierre Saintigny

  • Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

    Jean Bourhis;Jens Overgaard;Helene Audry;Kian K. Ang

  • Laryngeal Cancer in the United States: Changes in Demographics, Patterns of Care, and Survival

    Henry T. Hoffman;Kimberly Porter;Lucy H. Karnell;Jay S. Cooper

  • Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system.

    Jerry L. Barker;Adam S. Garden;K.Kian Ang;Jennifer C. O'Daniel

  • Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522

    K. Kian Ang;Qiang Zhang;David I. Rosenthal;Phuc Felix Nguyen-Tan

  • Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy.

    He Wang;Lei Dong;Jennifer O'Daniel;Radhe Mohan

  • CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.

    Vincent Grégoire;Peter Levendag;Kian K. Ang;Jacques Bernier

  • Radiation response of the central nervous system.

    T.E. Schultheiss;L.E. Kun;K.K. Ang;L.C. Stephens

  • Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines

    Vincent Grégoire;Kian Ang;Wilfried Budach;Cai Grau

  • Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225

    Nancy Lee;Jonathan Harris;Adam S Garden;William Straube

  • Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer

    K.K Ang;A Trotti;B.W Brown;A.S Garden

  • Hypoxia-Inducible mir-210 Regulates Normoxic Gene Expression Involved in Tumor Initiation

    Xin Huang;Lianghao Ding;Kevin L. Bennewith;Ricky T. Tong

  • Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial.

    Lester J Peters;Helmuth Goepfert;K.Kian Ang;Robert M Byers

Frequent Co-Authors

Adam S. Garden
Adam S. Garden The University of Texas MD Anderson Cancer Center
William H. Morrison
William H. Morrison The University of Texas MD Anderson Cancer Center
David I. Rosenthal
David I. Rosenthal The University of Texas MD Anderson Cancer Center
Randal S. Weber
Randal S. Weber The University of Texas MD Anderson Cancer Center
Lester J. Peters
Lester J. Peters Peter MacCallum Cancer Centre
Luka Milas
Luka Milas The University of Texas MD Anderson Cancer Center
Merrill S. Kies
Merrill S. Kies The University of Texas MD Anderson Cancer Center
Paul M. Harari
Paul M. Harari University of Wisconsin–Madison
Adel K. El-Naggar
Adel K. El-Naggar The University of Texas MD Anderson Cancer Center
Bonnie S. Glisson
Bonnie S. Glisson The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in the healthcare sector but not yet ready to commit to a traditional Medicine program, a range of online degrees and alternative career pathways can help you enter this dynamic field. Online learning offers flexibility, allowing you to balance your studies with personal and professional commitments while preparing for impactful roles in healthcare.

Many students are exploring options such as online healthcare administration programs. These degrees can lead to leadership and management positions in hospitals, clinics, and other healthcare organizations. If you’re seeking a more advanced credential, consider the cheapest mha online programs, which are designed for those aspiring to high-level administrative roles.

For those interested in clinical practice or advanced nursing, pursuing the cheapest dnp program can offer the skills necessary for clinical leadership and specialized patient care. Additionally, pharmacy is another promising area—innovative options like a 3-year online pharmd provide a streamlined pathway to becoming a licensed pharmacist.

Exploring these related online degrees can open doors to meaningful and diverse careers across the healthcare spectrum.

Best Scientists Citing K. Kian Ang